19 reports

Abstract: - Global Acute Coronary Syndrome Market to Reach $67.7 Billion by 2027 - Amid the COVID-19 crisis, the global market for Acute Coronary Syndrome estimated at US$30.3 Billion in the year 2020, is projected to reach a revised size of US$67.7 Billion by 2027, growing at a CAGR of 12.2% over the period 2020-2027....

  • Acute Coronary Syndrome
  • World
  • China
  • United States

Acute Coronary Syndrome (Cardiovascular) - Drugs in Development, 2021 Summary Acute Coronary Syndrome (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Acute Coronary Syndrome pipeline landscape. The report provides comprehensive information on the therapeutics under...

  • Acute Coronary Syndrome
  • Cardiology
  • World

The ongoing clinical trial research report- “2019 Acute Coronary Syndrome Ongoing Clinical Trials Study” analyzes the current scenario of all active Acute Coronary Syndrome trials across the world. The report presents top level analysis of global Acute Coronary Syndrome clinical trials across countries, companies and universities. It is designed...

  • Acute Coronary Syndrome
  • Clinical Trial
  • World
  • APAC

Comprehensive Pipeline Review on Ongoing Clinical and Pre-clinical studies Acute Coronary Syndrome Drug Development Pipeline Study is the latest publication from VPA Research with comprehensive information of Acute Coronary Syndrome pipeline products. The Acute Coronary Syndrome pipeline guide presents complete overview of drugs...

  • Acute Coronary Syndrome
  • World

“Acute Coronary Syndrome – Pipeline Insight, 2019” report outlays comprehensive insights of present scenario and growth prospects across Acute Coronary Syndrome. A detailed picture of the pipeline landscape is provided with summation of data from multiple sources with complete analysis by development stage, mechanism of action, route of administration...

  • Acute Coronary Syndrome
  • World

This report was created for global strategic planners who cannot be content with traditional methods of segmenting world markets. With the advent of a "borderless world", cities become a more important criteria in prioritizing markets, as opposed to regions, continents, or countries. This report covers the top 2,000 cities in over 200 countries....

  • Acute Coronary Syndrome
  • Therapy
  • World

This study covers the world outlook for Acute Coronary Syndrome (ACS) therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the...

  • Acute Coronary Syndrome
  • World
  • Gross Domestic Product
  • Disposable Income

The North America Cardiac Biomarkers Testing Market would witness market growth of 10.7% CAGR during the forecast period (2019–2025). Cardiac biomarkers are used when cardiac myocytes are damaged partially or completely, and measuring these biomarkers in serum or plasma is useful during the diagnosis of myocardial infarction. Cardiac...

  • Cardiovascular Disease
  • Biomarker
  • Heart Attack
  • Acute Coronary Syndrome
  • Point Of Care Testing
  • North America
  • Cardiovascular Disease Prevalence

Acute Coronary Syndrome Diagnosis Of Cardiovascular Diseases Detects the presence of biomarkers specific to acute coronary syndrome in patient's sample

  • Diagnostics
  • Acute Coronary Syndrome
  • Clinical Trial
  • World
  • Medical Devices Sales

Worldwide, an estimated 2 to 3 million people are hospitalized due to ACS annually. The acute coronary syndrome is a common complication of coronary heart disease. ACS refers to a broad range of diseases including Unstable angina, Non-ST segment elevation MI, ST-segment elevation MI. A sudden decrease in blood flow into the heart is observed,...

  • Acute Coronary Syndrome
  • Angina
  • Coronary Heart Disease
  • Therapy
  • World

Acute Coronary Syndrome ongoing clinical trials report provides comprehensive analysis and trends in global Acute Coronary Syndrome disease clinical trials. The research work analyzes the ongoing Acute Coronary Syndrome clinical trial trends across countries and companies. The report focuses on drugs and therapies being evaluated for...

  • Acute Coronary Syndrome
  • Clinical Trial
  • World

Acute Coronary Syndrome

  • Acute Coronary Syndrome
  • World
  • Japan
  • Cause-Specific Mortality Rate
  • Hospital Occupancy Rate

Fore Pharma announced the results of its Acute Coronary Syndrome patients study in a new report ‘Global Acute Coronary Syndrome Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Acute Coronary Syndrome epidemiology, Acute Coronary Syndrome diagnosed patients, and Acute Coronary Syndrome treatment...

  • Acute Coronary Syndrome
  • World
  • Spain
  • France
  • Japan
  • Germany
  • United States
  • Italy
  • United Kingdom

Fore Pharma announced the results of its Acute Coronary Syndrome patients study in a new report ‘Europe Acute Coronary Syndrome Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Acute Coronary Syndrome epidemiology, Acute Coronary Syndrome diagnosed patients, and Acute Coronary Syndrome treatment...

  • Acute Coronary Syndrome
  • Europe

Acute coronary syndrome

  • Drug Development
  • Cardiology
  • Surgery
  • Acute Coronary Syndrome
  • Marketing Research
  • United States
  • World
  • APAC
  • Drug Approval
  • Number Of Enterprises

Acute Coronary Syndrome

  • Acute Coronary Syndrome
  • World
  • Japan
  • Hospital Discharge
  • Cause-Specific Mortality Rate

## FORECAST: ACUTE CORONARY SYNDROME ## Executive Summary ## Market Overview and Trends ## Market Definition and Methodology ## Angiomax (bivalirudin) ## Brilinta (ticagrelor) ## Effient (prasugrel) ## Kengreal (cangrelor) ## Plavix (clopidogrel) ## Xarelto (rivaroxaban) ## Zontivity (vorapaxar) ## Primary Research Methodology ## TREATMENT: ACUTE CORONARY SYNDROME ## Executive Summary ## Primary Research Methodology ## Disease Definition and Diagnosis ## Patient Segmentation ## Country Treatment Trees ## Prescribing Trends ## EPIDEMIOLOGY: ACUTE CORONARY SYNDROME IN THE US, JAPAN, AND ##EU ## Executive Summary ## Disease Definition ## Global Variation ## Risk Factors ## Co-Morbidities Sources and Methodology Forecast Epidemiologist Insight Strengths and Limitations Bibliography

  • Acute Coronary Syndrome
  • United States
  • Japan
  • European Union
  • Smoking Prevalence
  • Infectious Disease Mortality

## Product Profiles – Acute Coronary Syndrome

  • Hospital
  • Therapy
  • Statins
  • Cardiovascular Drug
  • Acute Coronary Syndrome
  • ACE Inhibitor
  • World
  • Hospital Occupancy Rate
  • Infectious Disease Mortality

Acute Coronary Syndrome Diagnosis Of Cardiovascular Diseases Detects the presence of biomarkers specific to acute coronary syndrome in patient's sample

  • Diagnostics
  • Acute Coronary Syndrome
  • Clinical Trial
  • World
  • Medical Devices Sales